Clinician's Guide to Spinal Muscular Atrophy

Jump to:
Medical advisors icon

Meet our

Medical advisors

Edward Smith, M.D.

Edward Smith, MD

Melissa Wright, MD, PhD

SMA Presentation and Mimics

Written by Margaret Anne Rockwood | Last updated July 7th, 2026
✅ Medically reviewed by Edward Smith, MD

 

Spinal muscular atrophy (SMA) most commonly presents in infancy or early childhood and may appear similar to numerous other neuromuscular diseases. Presentation varies according to age of onset and disease severity. Traditionally, SMA has been classified into five phenotypes, ranging from severe infantile disease to mild adult-onset weakness.

SMA Type 0

SMA type 0 is the rarest and most severe form of SMA, with onset occurring before birth. Decreased fetal movement is often recognized during pregnancy, and affected infants present at birth with profound hypotonia, generalized weakness, poor spontaneous movement, and severe respiratory distress. Newborns frequently appear extremely “floppy” and usually require immediate ventilatory support because of respiratory muscle failure.

Deep tendon reflexes are absent, and facial weakness, tongue fasciculations, and difficulty swallowing are commonly present. Joint contractures and skeletal deformities may develop because of reduced fetal movement in utero. Intercostal and diaphragmatic weakness produce severe respiratory insufficiency immediately after delivery, and infants are unable to achieve developmental motor milestones such as head control or independent sitting. Cardiac abnormalities have also been reported in some cases.

Without aggressive supportive care and disease-modifying therapy (DMT), survival is typically severely shortened.

SMA Type 1

SMA type 1, also known as Werdnig-Hoffmann disease, is the most severe form that presents in infancy. Symptoms typically appear before 6 months of age. Infants demonstrate profound hypotonia, poor head control, generalized weakness, and decreased spontaneous movement. Affected infants often appear “floppy” and may have difficulty feeding, swallowing, and breathing.

Deep tendon reflexes are absent or markedly diminished. Intercostal muscle weakness produces paradoxical breathing with relative diaphragmatic sparing, leading to a bell-shaped chest deformity. Tongue fasciculations are characteristic and may aid diagnosis.

Without treatment, progressive respiratory failure develops early in life.

SMA Type 2

SMA type 2 presents between 6 and 18 months of age. Children are usually able to sit independently but never achieve independent ambulation. Weakness is predominantly proximal and symmetric, affecting the lower extremities more than the upper extremities. Tremor of the fingers, scoliosis, joint contractures, and respiratory compromise may develop over time.

Bulbar involvement is generally less severe than in type 1, though feeding difficulties can occur. Cognitive development remains normal.

SMA Type 3

SMA type 3, or Kugelberg-Welander disease, presents after 18 months of age and may occur during childhood or adolescence. Patients achieve independent walking but later develop progressive proximal muscle weakness, frequent falls, difficulty climbing stairs, and gait abnormalities. Loss of ambulation may occur later in life.

The weakness pattern resembles a limb-girdle muscular dystrophy. Respiratory complications are less prominent, and life expectancy is often near normal.

SMA Type 4

SMA type 4 is an adult-onset form characterized by mild proximal muscle weakness, usually presenting after age 18–21, often in the third decade of life or later. Disease progression is slow, and respiratory involvement is uncommon.

Common SMA Mimics

Because SMA presents with hypotonia and weakness, several neuromuscular and systemic disorders must be considered in the differential diagnosis.

Muscular Dystrophies

Duchenne muscular dystrophy (DMD) and congenital muscular dystrophies may resemble SMA because of progressive, symmetrical, proximal weakness and delayed motor milestones. However, muscular dystrophies are typically associated with elevated serum creatine kinase levels, preserved reflexes early in disease, and myopathic changes on EMG rather than denervation.

Congenital Myopathies

Congenital myopathies such as central core disease and nemaline myopathy may produce hypotonia and weakness during infancy. Unlike SMA, reflexes may be preserved, fasciculations are absent, and muscle biopsy demonstrates structural abnormalities within muscle fibers rather than neurogenic atrophy.

Peripheral Neuropathies

Hereditary motor sensory neuropathies, including Charcot-Marie-Tooth disease, can present with distal weakness and atrophy. Sensory involvement, foot deformities, and abnormal sensory nerve conduction studies help distinguish these conditions from SMA.

Myasthenic Disorders

Congenital myasthenic syndromes (CMS), transient neonatal myasthenia gravis or juvenile myasthenia gravis may cause hypotonia and feeding difficulties. Fluctuating weakness, ocular involvement, ptosis, and differing response to acetylcholinesterase inhibitors may help distinguish CMS from SMA. While not always the case, periods of improvement may suggest a neuromuscular junction disorder rather than SMA.

Cerebral Palsy

Infants with severe hypotonia may initially be misdiagnosed with cerebral palsy. However, cerebral palsy usually demonstrates upper motor neuron findings such as spasticity/hypertonia and hyperreflexia rather than areflexia and progressive denervation. EMG findings in cerebral palsy are expected to be essentially normal, unlike the neuropathic findings in SMA.

Metabolic and Mitochondrial Disorders

Metabolic myopathies and mitochondrial diseases may produce generalized weakness and developmental delay. Multisystem involvement, episodic deterioration, lactic acidosis, or cardiomyopathy may point toward metabolic etiologies.

Amyotrophic Lateral Sclerosis (ALS)

In adults, SMA type 4 may resemble amyotrophic lateral sclerosis. However, ALS involves both upper and lower motor neuron signs, whereas SMA primarily affects lower motor neurons.

Sources